Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemia.

Abstract

Bacillary angiomatosis is a well-recognized infection with cutaneous and systemic manifestations caused by Bartonella henselae or Bartonella quintana and occurs in immunocompromised patients. We report a case of B. quintana bacillary angiomatosis following fludarabine-based chemotherapy for chronic lymphocytic leukaemia that was refractory to standard treatment and was complicated by lymphadenopathy and osteomyelitis.

• Authors: Natasha E Holmes, Stephen Opat, Anthony Kelman, Tony M Korman
• Journal: Journal of medical microbiology (J Med Microbiol) Vol. 60 Issue Pt 1 Pg. 142-146 (Jan 2011) ISSN: 1473-5644 [Electronic] England
• PMID: 20947664 (Publication Type: Case Reports, Journal Article)

Chemical References

• Anti-Bacterial Agents
• Antineoplastic Agents
• Vidarabine
• fludarabine

Topics

• Aged
• Angiomatosis, Bacillary (diagnosis, drug therapy, microbiology, pathology)
• Anti-Bacterial Agents (therapeutic use)
• Antineoplastic Agents (therapeutic use)
• Bacteriological Techniques (methods)
• Bartonella quintana (isolation & purification)
• Drug Therapy (methods)
• Female
• Humans
• Immunocompromised Host
• Leukemia, Lymphocytic, Chronic, B-Cell (complications, drug therapy)
• Lymphatic Diseases (pathology)
• Microscopy (methods)
• Osteomyelitis (microbiology)
• Treatment Failure
• Vidarabine (analogs & derivatives, therapeutic use)